• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

有或无既往植入式心脏复律除颤器干预的室性心动过速患者接受消融治疗的特征及结局

Characteristics and Outcome of Patients with or without Previous Implantable Cardioverter Defibrillator Interventions Undergoing Ablation for Ventricular Tachycardia.

作者信息

Bencardino Gianluigi, Narducci Maria Lucia, Scacciavillani Roberto, Gabrielli Francesca Augusta, Pelargonio Gemma, Massetti Massimo, Crea Filippo, Lanza Gaetano Antonio

机构信息

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

Cardiology Institute, Catholic University of Sacred Heart, 00136 Rome, Italy.

出版信息

J Clin Med. 2024 Aug 22;13(16):4958. doi: 10.3390/jcm13164958.

DOI:10.3390/jcm13164958
PMID:39201099
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11355858/
Abstract

Catheter ablation (CA) is a well-established treatment in patients with ventricular tachycardia and appropriate implantable cardioverter defibrillator (ICD) therapies. We enrolled 57 consecutive carriers of ICD undergoing CA for electrical storm (ES). Our aim was to investigate differences in clinical, device-related, and electroanatomic features among patients who had history of appropriate ICD interventions before the ES compared to those who had not. The primary endpoint was a composite of death from any cause and recurrences of sustained VT, ventricular fibrillation, appropriate ICD therapy, or ES. During a median follow up of 39 months, 28 patients (49%) met the primary endpoint. Those with previous ICD interventions had a higher prevalence of late potentials and a greater unipolar low-voltage area at electroanatomic mapping. Patients who met the primary endpoint had a higher prevalence of ATP/shock episodes preceding the ES event. At Cox regression analysis, non-ischemic dilated cardiomyopathy (NIDCM), QRS duration, and previous ATP and/or shock before the ES were associated with arrhythmic recurrences and/or death. At multivariate analysis, NIDCM and previous shock were associated with arrhythmic recurrences and/or death. : A history of recurrent ICD therapies predicts worse outcomes when CA is needed because of ES. Although more studies are needed to definitively address this question, our data speak in support of an early referral for CA of ES.

摘要

导管消融术(CA)是治疗室性心动过速患者以及进行适当植入式心律转复除颤器(ICD)治疗的成熟方法。我们连续纳入了57例因电风暴(ES)接受CA治疗的ICD携带者。我们的目的是研究在ES之前有适当ICD干预史的患者与没有该病史的患者在临床、设备相关和电解剖特征方面的差异。主要终点是任何原因导致的死亡以及持续性室性心动过速、心室颤动、适当的ICD治疗或ES复发的综合结果。在中位随访39个月期间,28例患者(49%)达到主要终点。那些有既往ICD干预的患者在电解剖标测时晚期电位的患病率更高,单极低电压区更大。达到主要终点的患者在ES事件之前ATP/电击发作的患病率更高。在Cox回归分析中,非缺血性扩张型心肌病(NIDCM)、QRS时限以及ES之前的既往ATP和/或电击与心律失常复发和/或死亡相关。在多变量分析中,NIDCM和既往电击与心律失常复发和/或死亡相关。:当因ES需要进行CA时,既往反复进行ICD治疗的病史预示着更差的预后。尽管需要更多研究来明确解决这个问题,但我们的数据支持对ES尽早进行CA转诊。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/11355858/97d28a26b5fd/jcm-13-04958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/11355858/97d28a26b5fd/jcm-13-04958-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b2b/11355858/97d28a26b5fd/jcm-13-04958-g001.jpg

相似文献

1
Characteristics and Outcome of Patients with or without Previous Implantable Cardioverter Defibrillator Interventions Undergoing Ablation for Ventricular Tachycardia.有或无既往植入式心脏复律除颤器干预的室性心动过速患者接受消融治疗的特征及结局
J Clin Med. 2024 Aug 22;13(16):4958. doi: 10.3390/jcm13164958.
2
Impact of substrate-based ablation for ventricular tachycardia in patients with frequent appropriate implantable cardioverter-defibrillator therapy and dilated cardiomyopathy: Long-term experience with high-density mapping.基于基质的消融对频发恰当的植入型心律转复除颤器治疗和扩张型心肌病患者室性心动过速的影响:高密度标测的长期经验。
Rev Port Cardiol (Engl Ed). 2021 Nov;40(11):865-873. doi: 10.1016/j.repce.2021.11.006.
3
Implantable cardioverter-defibrillator programming and electrical storm: Results of the OBSERVational registry On long-term outcome of ICD patients (OBSERVO-ICD).植入式心脏复律除颤器程控与电风暴:ICD患者长期预后观察登记研究(OBSERVO-ICD)结果
Heart Rhythm. 2016 Oct;13(10):1987-92. doi: 10.1016/j.hrthm.2016.06.007. Epub 2016 Jun 9.
4
The role of catheter ablation in the management of patients with implantable cardioverter defibrillators presenting with electrical storm.导管消融在植入式心律转复除颤器患者发生电风暴管理中的作用。
Hellenic J Cardiol. 2017 Jan-Feb;58(1):51-56. doi: 10.1016/j.hjc.2017.01.019. Epub 2017 Feb 8.
5
Prophylactic catheter ablation of ventricular tachycardia before cardioverter-defibrillator implantation in patients with non-ischemic cardiomyopathy: Clinical outcomes after a single endocardial ablation.非缺血性心肌病患者在植入心脏复律除颤器前预防性导管消融室性心动过速:单次心内膜消融后的临床结果
J Arrhythm. 2015 Jun;31(3):122-9. doi: 10.1016/j.joa.2014.09.007. Epub 2015 Feb 4.
6
Electrical storm in patients with implantable cardioverter-defibrillator in the era of catheter ablation: Implications for better rhythm control.导管消融时代植入式心脏复律除颤器患者的电风暴:对更好的节律控制的启示
Heart Rhythm. 2015 Dec;12(12):2419-25. doi: 10.1016/j.hrthm.2015.07.034. Epub 2015 Jul 30.
7
Catheter ablation for the treatment of electrical storm in patients with implantable cardioverter-defibrillators: short- and long-term outcomes in a prospective single-center study.植入式心律转复除颤器患者电风暴治疗的导管消融:一项前瞻性单中心研究的短期和长期结果
Circulation. 2008 Jan 29;117(4):462-9. doi: 10.1161/CIRCULATIONAHA.106.686534. Epub 2008 Jan 2.
8
Impact of ventricular tachycardia ablation in subcutaneous implantable cardioverter defibrillator carriers: a multicentre, international analysis from the iSUSI project.室性心动过速消融对皮下植入式心脏转复除颤器携带者的影响:iSUSI 项目的多中心国际分析。
Europace. 2024 Mar 30;26(4). doi: 10.1093/europace/euae066.
9
Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.多非利特可降低室性心律失常和植入式心脏复律除颤器治疗的频率。
J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.
10
Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate.伴有植入式心律转复除颤器(ICD)电击的室性心动过速:何时药物治疗以及何时消融
Curr Cardiol Rep. 2017 Sep 13;19(11):105. doi: 10.1007/s11886-017-0924-0.

本文引用的文献

1
First-Line Catheter Ablation of Monomorphic Ventricular Tachycardia in Cardiomyopathy Concurrent With Defibrillator Implantation: The PAUSE-SCD Randomized Trial.心肌病伴埋藏式心脏复律除颤器患者中应用一线导管消融治疗单形性室性心动过速:PAUSE-SCD 随机试验。
Circulation. 2022 Jun 21;145(25):1839-1849. doi: 10.1161/CIRCULATIONAHA.122.060039. Epub 2022 May 4.
2
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.基质消融与抗心律失常药物治疗有症状性室性心动过速。
J Am Coll Cardiol. 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050.
3
Does Timing of Ventricular Tachycardia Ablation Affect Prognosis in Patients With an Implantable Cardioverter Defibrillator? Results From the Multicenter Randomized PARTITA Trial.
室性心动过速消融的时机是否影响植入型心律转复除颤器患者的预后?来自多中心随机 PARTITA 试验的结果。
Circulation. 2022 Jun 21;145(25):1829-1838. doi: 10.1161/CIRCULATIONAHA.122.059598. Epub 2022 Apr 3.
4
Comparison of the arrhythmogenic substrate for ventricular tachycardia in patients with ischemic vs non-ischemic cardiomyopathy - insights from high-density, multi-electrode catheter mapping.比较缺血性与非缺血性心肌病患者室性心动过速的致心律失常基质 - 来自高密度、多电极导管标测的见解。
J Interv Card Electrophysiol. 2023 Jan;66(1):5-14. doi: 10.1007/s10840-021-01088-7. Epub 2021 Nov 17.
5
Timing of Ablation and Prognosis of Patients With Electrical Storm and Scar-Related Left Ventricular Dysfunction.电风暴伴瘢痕相关左心室功能障碍患者消融时机与预后
Am J Cardiol. 2020 Dec 1;136:87-93. doi: 10.1016/j.amjcard.2020.09.010. Epub 2020 Sep 16.
6
High-Density Characterization of the Ventricular Electrical Substrate During Sinus Rhythm in Post-Myocardial Infarction Patients.心肌梗死后患者窦性心律时心室电基质的高密度特征。
JACC Clin Electrophysiol. 2020 Jul;6(7):799-811. doi: 10.1016/j.jacep.2020.04.008. Epub 2020 Jun 24.
7
Preventive or Deferred Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy and Implantable Defibrillator (BERLIN VT): A Multicenter Randomized Trial.缺血性心肌病和植入式除颤器患者的室性心动过速预防或延迟消融(BERLIN VT):一项多中心随机试验。
Circulation. 2020 Mar 31;141(13):1057-1067. doi: 10.1161/CIRCULATIONAHA.119.043400. Epub 2020 Jan 31.
8
Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives.心房颤动的导管消融:现状与未来展望
Cardiol Ther. 2020 Jun;9(1):45-58. doi: 10.1007/s40119-019-00158-2. Epub 2020 Jan 2.
9
Ventricular Tachycardia Ablation: Past, Present, and Future Perspectives.心室性心动过速消融:过去、现在和未来的观点。
JACC Clin Electrophysiol. 2019 Dec;5(12):1363-1383. doi: 10.1016/j.jacep.2019.09.015.
10
2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.2019 年 HRS/EHRA/APHRS/LAHRS 对 2015 年最佳植入式心脏复律除颤器编程和测试专家共识声明的重点更新。
Heart Rhythm. 2020 Jan;17(1):e220-e228. doi: 10.1016/j.hrthm.2019.02.034. Epub 2019 May 15.